Skip to content 
Metronomic Chemotherapy
Brief description of Metronomic chemotherapy
In metronomic chemotherapy, patients receive low-dose chemotherapy over a regular and extended period of time.
How does the modified chemotheraoy work?
The modified chemotherapy targets not only the tumour but also its environment. For example, it inhibits tumour vessels by inhibiting growth factors directly responsible for the production of new cancer vessels.
Surprisingly, metronomic chemotherapy also works by activating our immune system. Specific immune cells, called regulatory T cells, suppress the immune system and are associated with tumour growth. Metronomic chemotherapy inhibits these immune cells and thus cancels the suppression of the immune system.
Modified chemotherapy also has direct effects on cancer cells. Studies show that it can inhibit the growth of cancer cells and improve treatment outcomes.
Against which types of cancer can it be used?
According to studies, the modified chemotherapy can be used in the treatment of the following cancers:
- Breast cancer
- Lung cancer (bronchial carcinoma)
- Prostate cancer
- Brain cancer
- Colon and rectal cancer
- Multiple Myeloma
- Lymphoma
- Liver cancer
